Dominique Charmot,James P. Davidson,Fangling Lin,Jeffrey W. Jacobs,Natalia Blinova,Eric Labonte,Ingrid Langsetmo,Robert C. Blanks
申请号：
US15487967
公开号：
US20180064751A1
申请日:
2017.04.14
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention is directed to compositions and methods of removing potassium or treating hyperkalemia by administering pharmaceutical compositions of cation exchange polymers with low crosslinking for improved potassium excretion and for beneficial physical properties to increase patient compliance.
